View in EDS

EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients.

Saved in:
Bibliographic Details
Title: EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients.
Authors: Jittla P; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Graham DM; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Zhou C; CRUK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK., Halliwell J; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., O'Reilly S; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Aruketty S; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Azizi A; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Germetaki T; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Lowe J; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Little M; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Punnett G; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK., McMahon P; Medical Oncology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK., Benson L; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Carter L; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Krebs MG; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Thistlethwaite FC; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Darlington E; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Yorke J; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK., Cook N; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: natalie.cook17@nhs.net.
Source: ESMO open [ESMO Open] 2022 Oct; Vol. 7 (5), pp. 100550. Date of Electronic Publication: 2022 Aug 19.
Publication Type: Observational Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2022.100550